When is Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)

REBOA should be considered in patients with noncompressible life-threatening traumatic hemorrhage to bridge the gap between hemodynamic collapse and definitive hemorrhage control. 1

Primary Indications

REBOA serves as a temporary hemorrhage control method in specific clinical scenarios:

  1. Hemodynamically unstable patients with suspected pelvic bleeding:

    • Systolic blood pressure <90 mmHg or non-responders to direct blood products transfusion 1
    • Used as a bridge to definitive treatment (surgery or angioembolization)
  2. Noncompressible torso hemorrhage:

    • Severe intra-abdominal or retroperitoneal hemorrhage (Zone 1 deployment)
    • Pelvic hemorrhage (Zone 3 deployment) 1
  3. Patients in extremis:

    • Alternative to resuscitative thoracotomy in selected patients 1
    • Can be considered during ongoing cardiopulmonary resuscitation 2

Anatomical Considerations

REBOA deployment zones are critical for proper application:

  • Zone 1: From left subclavian artery to celiac trunk - for severe intra-abdominal/retroperitoneal hemorrhage
  • Zone 3: Infrarenal to aortic bifurcation - for pelvic hemorrhage 1
  • Zone 2: Pararenal area - generally avoided due to risk of visceral organ ischemia 1

Clinical Decision Algorithm

  1. Initial Assessment:

    • Identify suspected noncompressible torso hemorrhage
    • Assess hemodynamic status (SBP <90 mmHg or non-responder to initial resuscitation)
    • Determine source of bleeding (abdominal vs. pelvic)
  2. Procedural Considerations:

    • In major trauma patients with suspected pelvic trauma, consider early arterial vascular access via femoral artery 1
    • Consider partial-REBOA or intermittent-REBOA to decrease occlusion time and ischemic insult 1
  3. Timing:

    • REBOA should be deployed early, ideally within 3 hours of injury 1
    • Serves as a bridge to definitive hemorrhage control (surgery, angioembolization) 1

Effectiveness and Limitations

  • REBOA can temporarily improve hemodynamics in patients with severe hemorrhage 1, 2
  • Evidence demonstrating survival improvement is conflicting 1
  • Return of spontaneous circulation has been reported in 59% of patients in arrest after REBOA inflation 2

Important Caveats and Contraindications

  1. Technical limitations:

    • Potential vascular injury after pelvic trauma may limit catheter advancement 3
    • Procedural complication rate reported at 6.6% 2
  2. Time constraints:

    • REBOA should not be kept inflated for prolonged periods due to ischemic complications
    • Zone 3 REBOA may allow longer occlusion time (4-6 hours) than Zone 1 1
  3. Patient selection:

    • Only a small percentage (<3%) of severely injured patients may be candidates for REBOA 4
    • Quality evidence supporting clinical use is lacking 1

Alternative Approaches

When REBOA is not feasible or contraindicated, consider:

  • Temporary extra-peritoneal packing when bleeding is ongoing 1
  • Traditional approaches like cross-clamping the proximal aorta or pre-peritoneal pelvic packing 3

REBOA remains an evolving technique that requires specific training and should be performed within appropriate clinical settings. Current guidelines suggest it as a bridging intervention rather than a definitive treatment for traumatic hemorrhage.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.